AURA AURA BIOSCIENCES INC Management Changes 8-K Filing 2024 - CFO Departure Aura Biosciences' CFO Julie Feder is leaving the company effective October 25, 2024, and will provide consulting services until the end of the year; Amy Elazzouzi has been appointed as interim CFO with a salary of $360,000.Get access to all SEC 8-K filings of the AURA BIOSCIENCES INC